Recerca > Malalties cròniques, Cirurgia i Cures en Salut

Investigació translacional en medicina respiratòria

Nombre de publicacions
617
Cercador de publicacions
  • de Batlle, J; Vargiu, E; Torres, G; Massip, M; Miralles, F; Barbe, F

    The Implementation of an Integrated Care Platform for the Management of Complex Chronic Patients Can Successfully Reduce Unplanned Visits and Hospital Admissions

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 201 -. .

  • Pinilla, L; Zapater, A; Santamaria-Martos, F; Benitez, I; Targa, A; Barbe, F; de la Torre, MS

    Effect of Obstructive Sleep Apnea on the Aging Process: Role of Age and Sex

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 201 -. .

  • Zapater, A; Benitez, I; Targa, A; Bertran, S; Barbe, F; de la Torre, MS; Sanchez-de-la-Torre, A

    Effect of Obstructive Sleep Apnea in Different Phenotypes of Patients with Acute Coronary Syndrome

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 201 -. .

  • Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

    Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project

    Diabetes & metabolism 45 595-598. .

    [doi:10.1016/j.diabet.2018.04.002]

  • Montserrat-Capdevila, J; Godoy, P; Marsal, JR; Ortega, M; Barbe, F; Castan, MT; Seminario, MA; Pujol, J; Alseda, M

    Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers

    ATENCION PRIMARIA 51 602-609. .

    [doi:10.1016/j.aprim.2017.10.012]

  • Gómez-Domínguez, M. Rocío; Jáuregui-Abularach, Miguel E.; Aldomá-Balasch, Albina

    Response to ecg, november 2019

    REVISTA ESPANOLA DE CARDIOLOGIA 72 1080-1080. .

    [doi:10.1016/j.rec.2019.01.019]

  • Rodrigues, LS; Fagotti, J; D S Targa A; D Noseda AC; L Ilkiwa J; Chuproski, AP; W C Dorieux F; D Dos Santos P; M S Lima M

    Potential new therapies against a toxic relationship: neuroinflammation and Parkinson's disease

    BEHAVIOURAL PHARMACOLOGY 30 675-687. .

    [doi:10.1097/FBP.0000000000000512]

  • Sánchez E; Betriu À; López-Cano C; Hernández M; Fernández E; Purroy F; Bermúdez-López M; Farràs-Sallés C; Barril S; Pamplona R; Rius F; Hernández C; Simó R; Lecube A

    Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology 18 154-154. .

    [doi:10.1186/s12933-019-0962-6]

  • Oscullo, G; Torres, G; Campos-Rodriguez, F; Posadas, T; Reina-Gonzalez, A; Sapiña-Beltrán E; Barbe, F; Martinez-Garcia, MA

    Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges

    Journal of Clinical Medicine 8 -. .

    [doi:10.3390/jcm8111872]

  • Sapiña-Beltrán E; Torres, G; Benitez, I; Fortuna-Gutierrez, AM; Marquez, PP; Masa, JF; Corral-Penafiel, J; Drager, LF; Cabrini, M; Felez, M; Vazquez, S; Abad, J; Lee, CH; Aung, AT; Garcia-Rio, F; Casitas, R; Sanchez-de-la-Torre, M; Gaeta, AM; Barbe, F; Dalmases, M

    Prevalence, Characteristics, and Association of Obstructive Sleep Apnea with Blood Pressure Control in Patients with Resistant Hypertension

    Annals of the American Thoracic Society 16 1414-1421. .

    [doi:10.1513/AnnalsATS.201901-053OC]

  • Lopez-Cano, C; Gutierrez-Carrasquilla, L; Sanchez, E; Gonzalez, J; Yeramian, A; Marti, R; Hernandez, M; Cao, G; Ribelles, M; Gomez, X; Barril, S; Barbe, F; Hernandez, C; Simo, R; Lecube, A

    Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes

    Frontiers in Endocrinology 10 752-752. .

    [doi:10.3389/fendo.2019.00752]

  • Montserrat-Capdevila J; Godoy P; Marsal JR; Ortega M; Barbé F; Castañ MT; Seminario MA; Pujol J; Alsedà M

    Prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores.

    ATENCION PRIMARIA 51 589-590. .

    [doi:10.1016/j.aprim.2019.04.002]